A leading US healthcare and biopharmaceutical firm, Eli Lilly, is going to create an additional 800 jobs as part of a new €400m investment into Ireland as part of its global expansion.
The proposed project is expected to create new jobs for skilled engineers, scientists, and operations personnel, who will use the latest biologics manufacturing technology to produce life-changing treatments that patients need to address health challenges.
The company has announced that a €400m investment will be put into building a new facility in Co Limerick.
If the proposed project gets approval, the facility will need 500 people in the construction phase and will employ 300 pharma workers when it is finished.
The project is likely to build at Raheen Business Park near Shannon Airport and just under 5km from Limerick City center, is due to be submitted in the coming weeks.
The new facility will expand the company’s manufacturing network for biologic active ingredients, support increased demand for its existing products, and play a key role in bringing Lilly’s clinical pipeline — including its Alzheimer’s portfolio — to patients around the world.
Lilly’s president of manufacturing operations, Edgardo Hernandez said: “Over the past 40 years, we have continued to invest in Ireland in part because of supportive government policies that value life science innovation.
“This new Lilly campus in Limerick will allow us to expand our capacity to make innovative new medicines that can help treat some of the world’s most serious illnesses.”
Lilly has been operating in Ireland since 1978 and currently has over 2,300 employees at a manufacturing campus at Kinsale, a global business services center at Little Island in County Cork, and a commercial team dispersed across the country